Across TCGA pan-cancer cohorts, LRRC37A12P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LRRC37A12P data layer.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LRRC37A12P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LRRC37A12P expression acts as an unfavorable survival marker, although some lineages such as HNSC and OV show a favorable association.
HNSC, THCA, and LIHC are the cancer types where LRRC37A12P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.